Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
7,064.01
(
0.00%
)
US TECH 100
26,007.60
(
0.91%
)
Dow Jones
49,447.43
(
0.00%
)
Brent Oil
95.54
(
0.56%
)
Bitcoin
78,256.38
(
2.53%
)
News Focus
News Focus
Post# of 257435
Next 10
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Biowatch

Send PM Follow Ignore
Followers 63
Posts 6899
Boards Moderated 1
Alias Born 10/18/2003

Biowatch

Member Level

Re: DewDiligence post# 220801

Wednesday, 09/12/2018 4:46:21 PM

Wednesday, September 12, 2018 4:46:21 PM

Post# of 257435
Gene editing, sans CRISPR? See:

https://endpts.com/skirting-a-group-of-pioneers-gilead-partners-with-gene-editing-upstart-precision-bio-in-hunt-to-cure-hep-b/

Says Gilead avoided the big three gene-editing companies, as they did when they partnered with Sangamo.

The article postulates that Precision Biosciences may want to go public.
Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Trade Smarter with Thousands

Leverage decades of market experience shared openly.

Join Now